The SYNTap Test, a new biomarker test to help diagnose diseases like Parkinson’s, Lewy body dementia and Multiple System Atrophy, is now on the…
Scientists have made strides in improving the precision of diagnosing Alzheimer’s, but available diagnostic tools that measure Alzheimer’s biomarkers remain inaccessible for many patients….
Data on Cassava Sciences’ Alzheimer’s drug candidate, simufilam, found it was not only safe, but modified disease biomarkers at six months, and improved cognition…
New research suggests that certain Alzheimer’s blood biomarkers are associated with neurological symptoms of COVID-19 and older adults infected with SARS-CoV-2, the virus that…
One of Alzheimer’s disease’s key players, beta-amyloid presents a complex picture: “Every patient with Alzheimer’s disease has amyloid plaque in his or her brain….
A research team at the Korea Brain Research Institute discovered, for the first time, an increased specific expression of the Ube2h gene in the…